Company profile
Beacon Therapeutics
Transforming Vision, Transforming Lives
- Industry
- Biotechnology Research
- Employees
- 97
- Headquarters
- London
- Founded
- 2023
- Office locations
- 2
Beacon Therapeutics company summary
Beacon Therapeutics is a company in the Biotechnology Research industry, headquartered in London, founded in 2023. On LinkedIn the company has around 97 employees. The company lists 2 office locations.
What technology does Beacon Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Beacon Therapeutics
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The Company is harnessing the transformative power of gene therapy to deliver the most meaningful outcomes for severe ocular diseases. Beacon’s pipeline currently targets devastating blinding retinal diseases such as X-linked retinitis pigmentosa (XLRP) and geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Beacon Therapeutics’ investors include Advent Life Sciences, Forbion, Life Sciences at Goldman Sachs Alternatives, Oxford Science Enterprises, Retinal Degeneration Fund, Syncona Limited, and TCGX, among others. Learn more about Beacon Therapeutics at beacontx.com and follow on LinkedIn for more updates.
Where is Beacon Therapeutics located?
Beacon Therapeutics lists 2 office locations.
Compare companies similar to Beacon Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Beacon Therapeutics beacontx.com | Biotechnology Research | 97 | 2023 | London |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Beacon Therapeutics
What does Beacon Therapeutics do?
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The Company is harnessing the transformative power of gene therapy to deliver the most meaningful outcomes for severe ocular diseases. Beacon’s pipeline currently targets devastating blinding retinal diseases such as X-linked retinitis pigmentosa (XLRP) and geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Beacon Therapeutics’ investors include Advent Life Sciences, Forbion, Life Sciences at Goldman Sachs Alternatives, Oxford Science Enterprises, Retinal Degeneration Fund, Syncona Limited, and TCGX, among others. Learn more about Beacon Therapeutics at beacontx.com and follow on LinkedIn for more updates.
How many employees does Beacon Therapeutics have?
Beacon Therapeutics has around 97 employees on LinkedIn.
Where is Beacon Therapeutics headquartered?
Beacon Therapeutics is headquartered in London.
Where does Beacon Therapeutics have offices?
Beacon Therapeutics lists 2 office locations, including London, N7 9AS, GB; Cambridge, Massachusetts, US.
When was Beacon Therapeutics founded?
Beacon Therapeutics was founded in 2023.
Build a lead list from companies like Beacon Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.